NCT04547361View on ClinicalTrials.gov

A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

May 26, 2021

Study Completion Date

May 26, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

E2511

E2511 tablets.

DRUG

E2511 Matched Placebo

Placebo tablets matching E2511 tablets.

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT04547361 - A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants | Biotech Hunter | Biotech Hunter